Английская Википедия:Adverum Biotechnologies

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Infobox company Adverum Biotechnologies, formerly known as Avalanche Biotechnologies,[1] is a publicly traded[2] clinical stage gene therapy company located in Redwood City, California.[3] The company is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration (wet AMD).[4]

History

Avalanche Biotechnologies was founded in 2006 by Tom Chalberg, Mark Blumenkranz, Mitchell Finer, and Steven Schwartz.Шаблон:Cn Avalanche went public through an IPO in 2014, raising $102 million.[5]

In 2015, co-founder Tom Chalberg stepped down as CEO following Phase IIa trial results that were labeled as "iffy".[6]

In May 2016, Avalanche acquired Annapurna Therapeutics and changed its name to Adverum Biotechnologies.[7] It also changed its ticker symbol on the Nasdaq exchange from AAVL to ADVM.[7] In October 2016, former Annapurna Therapeutics CEO Amber Salzman became CEO of Adverum.[8]

In May 2018, CEO Amber Salzman left Adverum, and Chief Medical Officer Athena Countouriotis resigned after less than one year in the job.[9] In October 2018, Leone Patterson was named the new CEO of Adverum.[10]

In September 2019, Adverum announced six-month data from the first cohort of its phase I trial.[11] The stock price dropped 50% due to investor concerns over deterioration of vision that these trial subjects suffered, as well as several reports of occular inflammation.[11]

In June 2020, Laurent Fischer replaced Patterson as CEO of Adverum.[12]

In January 2022, the FDA granted Orphan Drug Designation to Adverum's ADVM-062, developed as a single intravitreal administration for blue-cone monochromacy by delivering a functional copy of the OPN1LW gene.[13]

In September 2022, Adverum announced that its first patient was dosed in the LUNA phase 2 clinical trial; the trial evaluates development for the treatment of wet age-related macular degeneration.[14][15]

References

Шаблон:Reflist